Rating History for Amylin Pharmaceuticals (AMLN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/28/2012 N/A Downgrade Neutral
(N/A)		 21.00
(N/A)		 15.39
(30.98)		 101.3% Details